Aspen grows Latin American assets with R5bn Viagra deal | Business

📆 14/01/45 08:30 م
📰 News24

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 80%

المملكة العربية السعودية أخبار أخبار

المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين

SA's biggest pharmaceutical group, Aspen Pharmacare, is deepening its footprint in Latin America with the $280 million (R5 billion) acquisition of a portfolio of specialist drugs, including Viagra. | News24_Business

Among other key products in the portfolio are cholesterol-lowering medicine Lipitor, anti-epileptic drug Lyrica, antidepressant Zoloft, hypertension medicine Norvasc and Celebrex, an anti-inflammatory medication. These are being acquired from Nasdaq-listed drug maker Viatris, with Aspen paying $150 million in cash for the portfolio and settling the balance through an extension of supply terms to Viatris.

"Due to the way the products have been integrated into Viatris' business, it is not possible to accurately determine or estimate the profit attributable to the products within Viatris," the group said.

اكتب تعليق

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Aspen seeks to lift Latin American business in R5bn deal with ViatrisThe drugmaker secured the commercialisation rights and related intellectual property for products such as Viagra and Lipitor
مصدر: BDliveSA - 🏆 12. / 63 اقرأ أكثر »

Into Africa – the insurance industry is burgeoningApio Group has formally rebranded to Olea South Africa after becoming part of Olea Group of companies in 2021.
مصدر: BusinessTechSA - 🏆 24. / 61 اقرأ أكثر »